Humoral and Cellular Immunity Are Significantly Affected in Renal Transplant Recipients, following Vaccination with BNT162b2.

Asimina FylaktouStamatia StaiEfstratios KasimatisAliki XochelliVasiliki NikolaidouAnastasia PapadopoulouGrigorios MyserlisGeorgios LiouliosDespoina AsouchidouMaria GiannakiEvangelia YannakiGeorgios TsoulfasAikaterini PapagianniMaria J Stangou

Published in: Vaccines (2023)

SARS-CoV-2-specific T-cell responses preceded the humoral ones, while two booster doses were needed for this group of immunocompromised patients to mount a protective immune response.

Keyphrases

immune response
sars cov
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
dendritic cells
intensive care unit
respiratory syndrome coronavirus
patient reported outcomes
inflammatory response
patient reported
extracorporeal membrane oxygenation